Status:
COMPLETED
Comparison of Two Needles (ProCore vs EchoTip) for the Diagnosis of Pancreatic Solid Mass Under EUS
Lead Sponsor:
VANBIERVLIET
Conditions:
Pancreatic Tumor
Fine Needle Aspiration
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The negative predictive value of fine needle aspiration under ultrasound endoscopy (EUS) for the diagnostic of solid pancreatic masses is 70% on average in the current literature with 22 gauge needles...
Eligibility Criteria
Inclusion
- Solid tumor of the pancreas (\<50% share or anechoic fluid) to receive a biopsy under endoscopic ultrasonography (EUS)
Exclusion
- Contraindications to the achievement of an upper gastrointestinal endoscopy
- Haemorrhagic disease, disorder of hemostasis and coagulation (PT \<60%, CaT\> 40 sec. and platelets \<60000/mm3)
- Pancreatic cystic mass (fluid quota valued at more than 50% of the mass lesion on imaging)
- Pregnant or lactating
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01479803
Start Date
October 1 2011
End Date
October 1 2012
Last Update
April 23 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital L'Archet 2, CHU Nice, BP 3079
Nice, France, 06202